<?xml version="1.0" encoding="UTF-8"?>
<p>Exploring and exploiting medicinal plants for antiviral activity should be premised on the demonstration of prophylactic and/or therapeutic efficacy at an optimal amount in metabolic fluid. Similarly, plants and their bioactive metabolites have been shown to modulate immunological activities making them suitable candidates for biological response modifiers with the potential to alleviate symptoms and prevent death associated with infectious viral outbreak (
 <xref rid="B143" ref-type="bibr">Kurokawa et al., 2010</xref>). Therefore, the Africa Centers for disease Control and Prevention (Africa CDC) has provided standard guidelines for Member States when herbal remedies or medicines are proclaimed or developed in their countries (
 <xref rid="B6" ref-type="bibr">Africa CDC, 2020</xref>)
 <italic>.</italic>
</p>
